112 related articles for article (PubMed ID: 21440979)
1. Complete remission of recurrent and refractory uterine epithelioid leiomyosarcoma using weekly administration of bevacizumab and temozolomide.
Takano M; Kikuchi Y; Susumu N; Kudoh K; Kita T; Kouta H; Goto T; Furuya K
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):236-8. PubMed ID: 21440979
[No Abstract] [Full Text] [Related]
2. [Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions].
Lebrun-Frenay C
Rev Neurol (Paris); 2014 Apr; 170(4):235-6. PubMed ID: 24776742
[No Abstract] [Full Text] [Related]
3. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series.
Ferriss JS; Atkins KA; Lachance JA; Modesitt SC; Jazaeri AA
Int J Gynecol Cancer; 2010 Jan; 20(1):120-5. PubMed ID: 20130512
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide in uterine leiomyosarcomas.
Anderson S; Aghajanian C
Gynecol Oncol; 2005 Jul; 98(1):99-103. PubMed ID: 15916799
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
[TBL] [Abstract][Full Text] [Related]
7. Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme.
Kilickap S; Oztoprak I; Yucel B
Acta Oncol; 2012 Apr; 51(4):544-6. PubMed ID: 22201408
[No Abstract] [Full Text] [Related]
8. Activity of trabectedin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma.
Tewari D; Saffari B; Cowan C; Wallick AC; Koontz MZ; Monk BJ
Gynecol Oncol; 2006 Sep; 102(3):421-4. PubMed ID: 16797679
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab for glioblastoma multiforme after traumatic subarachnoid hemorrhage.
Lukas RV; Goldenberg F; Nicholas MK
J Clin Neurosci; 2012 Sep; 19(9):1310-1. PubMed ID: 22721885
[TBL] [Abstract][Full Text] [Related]
10. Role of bevacizumab in uterine leiomyosarcoma.
Bogani G; Ditto A; Martinelli F; Signorelli M; Chiappa V; Fonatella C; Sanfilippo R; Leone Roberti Maggiore U; Ferrero S; Lorusso D; Raspagliesi F
Crit Rev Oncol Hematol; 2018 Jun; 126():45-51. PubMed ID: 29759566
[TBL] [Abstract][Full Text] [Related]
11. [Use of angioneogenesis inhibitor monoclonal antibody following standard therapy in recurrent or progressive glioblastoma multiforme].
Pikó B; Bassam A; Nagy KA; Török E; Vághy R; Vargáné Tamás R; Puskásné Szatmári K
Magy Onkol; 2012 Sep; 56(3):166-70. PubMed ID: 23008824
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide or bevacizumab for spinal cord high-grade gliomas.
Kaley TJ; Mondesire-Crump I; Gavrilovic IT
J Neurooncol; 2012 Sep; 109(2):385-9. PubMed ID: 22678696
[TBL] [Abstract][Full Text] [Related]
13. Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features.
Zhang W; Lin Y; Chen B; Song SW; Jiang T
Childs Nerv Syst; 2010 Jan; 26(1):137-43. PubMed ID: 19823845
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma.
Narayana A; Golfinos JG; Fischer I; Raza S; Kelly P; Parker E; Knopp EA; Medabalmi P; Zagzag D; Eagan P; Gruber ML
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):383-9. PubMed ID: 18793954
[TBL] [Abstract][Full Text] [Related]
15. Reply to T.J. Kruser et al.
Chinot OL; Taphoorn MJ; Bais C; Bourgon R; Phillips HS; Abrey LE; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Cloughesy T
J Clin Oncol; 2016 Apr; 34(11):1282-3. PubMed ID: 26884575
[No Abstract] [Full Text] [Related]
16. Irradiation and bevacizumab in high-grade glioma retreatment settings.
Niyazi M; Ganswindt U; Schwarz SB; Kreth FW; Tonn JC; Geisler J; la Fougère C; Ertl L; Linn J; Siefert A; Belka C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):67-76. PubMed ID: 21030162
[TBL] [Abstract][Full Text] [Related]
17. A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.
Rehman S; Brock C; Newlands ES
Am J Clin Oncol; 2006 Feb; 29(1):106-7. PubMed ID: 16462515
[No Abstract] [Full Text] [Related]
18. Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient?
Kruser TJ; Mehta MP; Kozak KR
J Clin Oncol; 2016 Apr; 34(11):1281-2. PubMed ID: 26884565
[No Abstract] [Full Text] [Related]
19. Current evidence of temozolomide and bevacizumab in treatment of gliomas.
Nanegrungsunk D; Onchan W; Chattipakorn N; Chattipakorn SC
Neurol Res; 2015 Feb; 37(2):167-83. PubMed ID: 25033940
[TBL] [Abstract][Full Text] [Related]
20. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?
Desjardins A
Nat Rev Neurol; 2015 Aug; 11(8):429-30. PubMed ID: 26195258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
